Pre-order Enquiry
Request Free Sample
Healthcare
Aerospace & Defence
Agriculture
Automations
Chemicals & Advanced Materials
Food & Beverages
Information & Communication Technology
Oil & Gas
Power & Energy
About the Cardiac Resynchronization Therapy Defibrillator (CRT-D) Market
Heart failure, a condition when the heart cannot pump enough blood to meet the body’s need, is one of the leading causes of death. Heart failure and stroke, if occurred together, can lead to major health problems or cause sudden death.
Irregularity in ventricular rate can lead to reduction of diastolic dysfunction, a condition when there is abnormality in how the heart fills with blood causing pressure in the pulmonary vessel, leading to AF. Hence, patients with high risk of AF use CRT-D devices to minimize the risk associated with irregular heartbeat. The use of CRT-D devices enhances the functioning of the heart's electrical activity and improves heart rhythm. These devices are small in size and are placed below the collar bone.
Technavio’s analysts forecast the global cardiac resynchronization therapy defibrillator (CRT-D) market to grow at a CAGR of 8.36% during the period 2016-2020.
Covered in this report
The report covers the present scenario and the growth prospects of the global cardiac resynchronization therapy defibrillator (CRT-D) market for 2016-2020. To calculate the market size, we use revenue generated from the sales of various types of CRT-D devices.
The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA
Technavio's report, Global Cardiac Resynchronization Therapy Defibrillator (CRT-D) Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
• Boston Scientific
• Medtronic
• St. Jude Medical
• LivaNova
Other prominent vendors
• BIOTRONIK
• Cook Medical
• Spectranetics
Market driver
• Clinical considerations
• For a full, detailed list, view our report
Market challenge
• High cost
• For a full, detailed list, view our report
Market trend
• Growing popularity of robotic-assistance surgery
• For a full, detailed list, view our report
Key questions answered in this report
• What will the market size be in 2020 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
Heart failure, a condition when the heart cannot pump enough blood to meet the body’s need, is one of the leading causes of death. Heart failure and stroke, if occurred together, can lead to major health problems or cause sudden death.
Irregularity in ventricular rate can lead to reduction of diastolic dysfunction, a condition when there is abnormality in how the heart fills with blood causing pressure in the pulmonary vessel, leading to AF. Hence, patients with high risk of AF use CRT-D devices to minimize the risk associated with irregular heartbeat. The use of CRT-D devices enhances the functioning of the heart's electrical activity and improves heart rhythm. These devices are small in size and are placed below the collar bone.
Technavio’s analysts forecast the global cardiac resynchronization therapy defibrillator (CRT-D) market to grow at a CAGR of 8.36% during the period 2016-2020.
Covered in this report
The report covers the present scenario and the growth prospects of the global cardiac resynchronization therapy defibrillator (CRT-D) market for 2016-2020. To calculate the market size, we use revenue generated from the sales of various types of CRT-D devices.
The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA
Technavio's report, Global Cardiac Resynchronization Therapy Defibrillator (CRT-D) Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
• Boston Scientific
• Medtronic
• St. Jude Medical
• LivaNova
Other prominent vendors
• BIOTRONIK
• Cook Medical
• Spectranetics
Market driver
• Clinical considerations
• For a full, detailed list, view our report
Market challenge
• High cost
• For a full, detailed list, view our report
Market trend
• Growing popularity of robotic-assistance surgery
• For a full, detailed list, view our report
Key questions answered in this report
• What will the market size be in 2020 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
